肿瘤相关血栓的形成及其治疗

doi:10.3760/cma.j.issn.1673-422X.2016.11.013

国际肿瘤学杂志 ›› 2016, Vol. 43 ›› Issue (11): 852-854.doi: 10.3760/cma.j.issn.1673-422X.2016.11.013

肿瘤相关血栓的形成及其治疗

万闹，卢宁

830000 乌鲁木齐，新疆医科大学研究生学院（万闹）；兰州军区乌鲁木齐总医院肿瘤科（卢宁）

收稿日期:2016-02-24 出版日期:2016-11-08 发布日期:2016-11-02
通讯作者: 卢宁，Email: luning407@sina.com E-mail:luning407@sina.com

The formation and treatment of tumor associated thrombosis

Wan Nao, Lu Ning

Graduate School of Xinjiang Medical University, Urumqi 830000, China

Received:2016-02-24 Online:2016-11-08 Published:2016-11-02
Contact: Lu Ning E-mail:luning407@sina.com

摘要/Abstract

摘要： 恶性肿瘤患者易并发静脉血栓形成，是恶性肿瘤患者第二大致死因素。肿瘤并发血栓形成的机制与肿瘤类型、治疗、转移、遗传以及肿瘤本身有关。对肿瘤患者伴发静脉血栓的风险进行评估，针对高危患者给予针对性的预防性抗凝措施，对肿瘤患者提高生命质量和延长生存期有重要意义。

关键词: 肿瘤, 血栓形成, 治疗

Abstract: Patients with malignant tumor are easy to be complicated with venous thrombosis, which is the second leading cause of death for patients with malignant tumor. The mechanism of tumor thrombus formation is related to tumor type, treatment, metastasis, heredity and tumor itself. Evaluating the risk of venous thrombosis in patients with cancer and providing targeted preventive anticoagulation measures for highrisk patients have important significances for improving the quality of life and prolonging the survival period of patients with cancer.

Key words: Neoplasms, Thrombosis, Therapy

万闹，卢宁. 肿瘤相关血栓的形成及其治疗[J]. 国际肿瘤学杂志, 2016, 43(11): 852-854.

Wan Nao, Lu Ning. The formation and treatment of tumor associated thrombosis[J]. Journal of International Oncology, 2016, 43(11): 852-854.

参考文献

［1］ CorralesRodriguez L, Blais N. Lung cancer associated venous thromboembolic disease: a comprehensive review［J］. Lung Cancer, 2012, 75(1): 1-8. DOI: 10.1016/j.lungcan.2011.07.004. ［2］ Tiedje V, Dunkler D, Ay C, et al. The role of fibrinogen plasma levels, the 455G>A fibrinogen and the factor ⅹⅢ A subunit (FⅹⅢA) Val34Leu polymorphism in cancerassociated venous thrombosis［J］. Thromb Haemost, 2011, 106(5): 908-913. DOI: 10.1160/TH11040278. ［3］ Jean M. Prophylaxis against venous thromboembolism in ambulatory patients with cancer［J］. N Enql J Med, 2014, 370(26): 2515-2519. DOI: 10.1056/NEJMra1401468. ［4］ Rao B, Gao Y, Huang J, et al. Mutations of p53 and Kras correlate TF expression in human colorectal carcinomas: TF downregulation as a marker of poor prognosis［J］. Int J Colorectal Dis, 2011, 26(5): 593-601. DOI: 10.1007/s00384-011-1164-1. ［5］ Geddings JE, Mackman N. Tumorderived tissue factorpositive microparticles and venous thrombosis in cancer patients［J］. Blood, 2013, 122（11）: 1873-1880. DOI: 10.1182/blood-2013-04-460139. ［6］ Welsh J, Smith JD, Yates KR, et a1. Tissue factor expression determines tumour cell coagulation kinetics［J］. Int J Lab Hematol, 2012, 34 (4): 396-402. DOI: 10.1111/j.1751553X.2012.01409.x. ［7］ Ageno W, Cosmi B, Ghirarduzzi A, et al. The negative predictive value of Ddimer on the risk of recurrent venous thromboembolism in patients with multiple previous events: a prospective cohort study［J］. Am J Hematol, 2012, 87(7): 713715. DOI: 10.1002/ajh.23198. ［8］ Tanaka N, Kikuchi E, Matsumoto K, et al. Prognostic value of plasma fibrinogen levels in patients with localized upper tract urothelial carcinoma［J］. BJU Int, 2013, 6(111): 857-864. DOI: 10.1111/j.1464-410X.2012.11353.x. ［9］ Linnemann B, Lind hoffLast E. Risk factors, management and primary prevention of thrombotic complications related to the use of central venous catheters［J］. Vasa, 2012, 41(5): 319-332. DOI: 10.1024/0301-1526/a000217. ［10］ Saccullo G, Malato A, Raso S, et al. Cancer patients requiring interruption of long-term warfarin because of surgery of chemotherapy induced thrombocytopenia: the use of fixed subtherapeutic doses of lowmolecular weight heparin［J］. Am J Hematol, 2012, 87(4): 388-391. DOI: 10.1002/ajh.23122. ［11］ Pabinger I, Thaler J, Ay C. Biomarkers for prediction of venous thromboembolism in cancer［J］. Blood, 2013, 122（12）: 2011-2018.DOI: 10.1182/blood-2013-04-460147. ［12］ Khorana AA, Kuderer NM, Culakova E, et al. Development and validation of a predictive model forchemotherapyassociated thrombosis［J］. Blood, 2008, 111(10): 4902-4907. DOI: 10.1182/blood200710116327. ［13］ Nan H, Hutter CM, Lin Y, et al. Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants［J］. JAMA, 2015, 313(11): 1133-1142. DOI: 10.1001/jama.2015.1815. ［14］ Lyman GH, Bohlke K, Khorana AA， et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinicaloncology clinical practice guideline update 2014［J］. J Clin Oncol, 2015, 33(6): 654656. DOI: 10.1200/JCO.2014.59.7351. ［15］ Agnelli G, George DJ, Kakkar AK, et al. Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer［J］. N Engl J Med, 2012, 366 (7): 601-609. DOI: 10.1056/NEJMoa1108898. ［16］ Cohen AT, Spiro TE, Spyropoulos AC, et al. Rivaroxaban for thromboprophylaxis in acutely ill medical patients［J］. N Engl J Med, 2013, 368: 1945-1946. DOI: 10.1056/NEJMc1303641.

[1]	刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲. 血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325.
[2]	钱晓涛, 石子宜, 胡格, 吴晓维. Ⅲ~ⅣA期食管鳞状细胞癌放化疗后行巩固化疗的疗效：一项真实世界临床研究[J]. 国际肿瘤学杂志, 2024, 51(6): 326-331.
[3]	杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊. 局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337.
[4]	袁健, 黄燕华. Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343.
[5]	陈红健, 张素青. 血清miR-24-3p、H2AFX与肝癌患者临床病理特征及术后复发的关系研究[J]. 国际肿瘤学杂志, 2024, 51(6): 344-349.
[6]	郭泽浩, 张俊旺. PFDN及其亚基在肿瘤发生发展中的作用[J]. 国际肿瘤学杂志, 2024, 51(6): 350-353.
[7]	张百红, 岳红云. 新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358.
[8]	许凤琳, 吴刚. EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363.
[9]	王盈, 刘楠, 郭兵. 抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369.
[10]	张蕊, 褚衍六. 基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375.
[11]	高凡, 王萍, 杜超, 褚衍六. 肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381.
[12]	王丽, 刘志华, 杨伟洪, 蒋凤莲, 李全泳, 宋浩杰, 鞠文东. ROS1突变肺腺鳞癌合并脑梗死为主要表现的Trousseau综合征1例[J]. 国际肿瘤学杂志, 2024, 51(6): 382-384.
[13]	刘静, 刘芹, 黄梅. 基于SMOTE算法的食管癌放化疗患者肺部感染的预后模型构建[J]. 国际肿瘤学杂志, 2024, 51(5): 267-273.
[14]	杨琳, 路宁, 温华, 张明鑫, 朱琳. 炎症负荷指数与胃癌临床关系研究[J]. 国际肿瘤学杂志, 2024, 51(5): 274-279.
[15]	王俊毅, 洪楷彬, 纪荣佳, 陈大朝. 癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285.

肿瘤相关血栓的形成及其治疗

The formation and treatment of tumor associated thrombosis

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价